Aetna Denial Appeal - Free AI Letter Generator | Counterclaim

Common Aetna denial patterns

These are the denial patterns we see most often from Aetna members based on publicly-reported insurer policies and regulator findings. The right appeal approach depends on which pattern matches your denial.

• Medical-necessity denials citing a specific Aetna Clinical Policy Bulletin (CPB)
• Experimental / investigational denials - Aetna designates many newer cancer therapies and orthopedic procedures as experimental
• Prior-authorization denials for specialty drugs administered through CVS Caremark
• Bariatric surgery and infertility denials - Aetna applies strict member-eligibility criteria
• Out-of-network denials with limited reimbursement to billed charges
• Skilled nursing facility and home-health denials in Medicare Advantage
• Behavioral-health denials administered through Aetna Behavioral Health - subject to MHPAEA parity

How Aetna's appeal process works

Aetna gives most members 180 days from the denial notice to file a written appeal. Aetna typically offers two levels of internal appeal followed by external review (state-administered for fully insured plans, IRO for self-funded ERISA plans). Aetna's denials almost always cite a specific Clinical Policy Bulletin (CPB) by number - identify and contest that exact CPB in your appeal. Aetna Better Health (Medicaid managed care) follows state Medicaid appeal procedures rather than the commercial process.

Step 1: Find the CPB. Aetna's denial notice will reference the Clinical Policy Bulletin by number; pull the current version from aetna.com to see the precise criteria. Step 2: Mark the deadline - 180 days from the denial date for most commercial members. Step 3: Submit a written first-level appeal to the address on your EOB; the standard national appeals address is PO Box 14463, Lexington KY 40512, but plan-specific routing on your denial takes precedence. Step 4: Attach a physician letter of medical necessity that quotes the specific CPB section and explains how your case satisfies it (or how the CPB conflicts with current peer-reviewed standard of care for your diagnosis). Step 5: Mark the appeal expedited if delay would jeopardize your health - decision within 72 hours. Step 6: If level 1 is denied, file a second-level internal appeal (most Aetna commercial plans allow two levels). Step 7: Request external review after internal exhaustion - state IRO for fully insured plans, plan-administrator-selected IRO for ERISA self-funded plans. Step 8: For Aetna Better Health Medicaid members, the appeal process follows the state Medicaid agency's procedures including the right to a fair hearing.

What makes Aetna appeals succeed

The most successful Aetna appeals share several traits. First, they engage with the exact Clinical Policy Bulletin Aetna cited - quoting the relevant section and either matching the criteria with case-specific clinical evidence or showing that the CPB lags the current standard of care (with peer-reviewed literature attached, including specialty-society guidelines and recent FDA labeling where relevant). Second, they identify the correct product line and route accordingly: commercial plan appeals go to the standard appeals unit, ASO self-funded ERISA appeals follow the plan document, Medicare Advantage reconsiderations go to the MA appeals unit and auto-forward to MAXIMUS at level 2, and Aetna Better Health Medicaid appeals follow state Medicaid rules with the binding state-fair-hearing escalation. Third, they request a board-certified specialist reviewer in the relevant clinical area - Aetna's standard is a same-or-similar-specialty reviewer at level 2 internal appeal, and explicitly requesting it puts the appeal in the correct queue. Fourth, they cite the deemed-denied right under federal rule (if Aetna misses the response deadline) to preserve escalation timing. Fifth, for bariatric, infertility, and behavioral-health denials where Aetna applies eligibility-tightening criteria, they document the case-specific clinical history that satisfies each criterion the CPB enumerates rather than offering a generalized argument. Sixth, they preserve a complete written record by sending the appeal via certified mail with return receipt, which is admissible evidence of timely filing in any subsequent regulatory or external-review proceeding.

Recent regulatory and public-record context

CVS Aetna was named alongside UnitedHealthcare and Humana in the October 2024 Senate Permanent Subcommittee on Investigations report on Medicare Advantage post-acute-care prior-authorization denials. The HHS Office of Inspector General's April 2022 audit of MA prior-authorization denials by major plans (including Aetna) found that 13 percent of denials met traditional Medicare coverage rules. Aetna also paid a multi-state settlement in 2018-2019 over alleged disclosure of HIV status on member mailings, a class-action matter unrelated to appeals but illustrative of the regulatory exposure that informs Aetna's compliance posture.

Frequently asked questions: Aetna appeals

Related guides for Aetna members